Jacques Marius Seron

Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium.

Biocode Hycel SA provides biotechnology research services. The firm offers products for the three important IVD sectors: hematology, immunoassays and clinical chemistry. It also has operations in France. The company was founded in September 1989 and is headquartered in Liège, Belgium.

Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium.

Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg.

Technowal SA is a regional private equity firm and a wholly-owned subsidiary of SRIW-Société Régionale d'Investissement de Wallonie NV, a government entity controlled by the Region of Walloon. Founded in 1989, Technowal is located in Liège in eastern Belgium. Part of the New Technologies division of the SRIW group, the firm invests on behalf of SRIW and aims to promote regional economic development in Wallonia. Technowal's fellow subsidiary CD Technicom SA specializes in investments in the telecommunications and IT industries. Environment-related investments are covered by Ecotech Finance SA, majority-owned by SRIW.

Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline.

Aseptic Technologies NV engages in the development and manufacture of aseptic production equipment. It offers AT-closed Vial, filling lines, isolator and barrier, and kits for aseptic filling. The company was founded in 2002 and is headquartered in Gembloux, Belgium.

Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium.